Vaccine Development Always Prioritizes Safety Aspects

Liputan6.com, Jakarta Safety is always the top priority of every phase vaccine development. This aspect has been a concern since the vaccine preparations are still in the pre-clinical stage. Each phase of clinical trials will not be able to advance to the next phase if there is an element of insecurity in vaccine development being carried out.

Chairman of the National Commission on Post-Immunization Follow-up Events (Komnas KIPI) Prof. Dr. dr. Hindar Irawan Satari explained, “Vaccine safety has been assessed since the vaccine was designed and before it was tested on humans.”

However, Hindra admits that vaccines are biological products so that the level of safety may not reach 100 percent. This was revealed in the Productive Dialogue with the theme ‘Vaccine Safety and Responding to KIPI (Post-Immunization Follow-up Events)’ which was held online at the Media Center Committee for Handling COVID-19 and National Economic Recovery (KPCPEN), Thursday (19/11/2020).

So according to him, there could be a follow-up after giving vaccine such as complaints of pain, bleeding, or swelling. “But it’s all a natural reaction to a vaccine.”

“If there is a dangerous substance in the vaccine, it must have been known since vaccine development in its early phase. In addition, all matters related to vaccines have been informed transparently and it is impossible to hide it, “he continued.

Hindra hopes that the public will seek and get information about vaccines through official information.

“We should not even be carried away by the flow of news that cannot be accounted for, so it will instead provide disturbing information and increase anxiety. This immunization safety observation activity has been carried out since before vaccine given to humans, “he concluded.

– .